...
首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >Facile preparation of metal organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment
【24h】

Facile preparation of metal organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment

机译:基于金属有机框架的疏水性抗癌药物递送纳米型靶向和增强癌症治疗的容易制剂

获取原文
获取原文并翻译 | 示例

摘要

Nowadays, cancer has been one of the major threats to human beings throughout the world. Nanomedicines have been demonstrated as a promising candidate for cancer chemotherapy. In this work, we facilely constructed a RGD (Arg-Gly-Asp) modified camptothecin@zeolitic imidazolate framework-8 (RGD@CPT@ZIF-8) as a novel metal-organic frameworks-based hydrophobic drug delivery system for targeted and enhanced cancer treatment. In our system, the nanoplatform exhibited the superior property of target to the cancer cells due to the function with RGD. More importantly, the RGD@CPT@ZIF-8 nanoplatform has shown the enhanced cancer cell treatment due to the excellent pH-responsive hydrophobic anticancer drug delivery and intracellular ROS generation. With the excellent targeting and enhanced therapy performance, we envision that the hydrophobic anticancer drug delivery system could become a potential therapeutic agent for targeted cancer treatment.
机译:如今,癌症一直是全世界对人类的主要威胁之一。 纳米美胺已被证明是癌症化疗的有希望的候选者。 在这项工作中,我们将RGD(Arg-Gly-ASP)修饰的Camptothecin @ Zeolitic Imidazolate框架-8(RGD @ CPT @ ZIF-8)构建为基于新的金属 - 有机框架的疏水药物输送系统,用于靶向和增强 癌症治疗。 在我们的系统中,由于RGD的功能,纳米纳薄表现出靶向靶向癌细胞的优越性。 更重要的是,RGD @ CPT @ ZIF-8纳米纳薄形式显示出由于优异的pH响应疏水性抗癌药物输送和细胞内ROS产生而增强的癌细胞治疗。 凭借优异的靶向和增强的治疗性能,我们设想疏水性抗癌药物递送系统可能成为针对靶向癌症治疗的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号